Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: V08CA

Ablavar (previously Vasovist)(gadofosveset trisodium)

Magnetic Resonance Angiography

Marketing Authorisation Holder: TMC Pharma Services Ltd.

EMA Authorisation: 03/10/2005

INN: gadofosveset trisodium

Indication

This medicinal product is for diagnostic use only. Ablavar is indicated for contrast-enhanced magnetic resonance angiography (CE-MRA) for visualisation of abdominal or limb vessels in adults only, with suspected or known vascular disease.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Ablavar (previously Vasovist) — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.